Global Kinase Inhibitors For Cancer Treatment Market size is expected to be worth around US$ 151.7 Billion by 2034.
Global Plasma-Derived Drugs Market size is expected to be worth around US$ 35.5 Billion by 2034 from US$ 16.3 Billion in 2024.
As Breast Cancer Awareness Month approaches in October, advances in antibody–drug conjugates, endocrine therapy and molecular profiling are changing the management of metastatic breast cancer.
- 10x Genomics TXG-- stock surged 820% from $11.16 to $102.81 then fell 26% to $76, driven by Atera SORA-- product optimism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results